| Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects. (NCT04877834) | University of Karachi | 2021-09-18 |
| Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients (NCT05019040) | Zhejiang Palo Alto Pharmaceuticals, Inc. | 2021-09-17 |
| Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA) (NCT05056389) | Oslo University Hospital | 2021-09-17 |
| ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma (NCT04904185) | Inge Marie Svane | 2021-09-17 |
| A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia (NCT04996030) | Syros Pharmaceuticals | 2021-09-17 |
| A Study of Lazertinib (JNJ-73841937) in Healthy Participants (NCT05076877) | Janssen Research & Development, LLC | 2021-09-17 |
| Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT05052528) | University of California, Davis | 2021-09-17 |
| Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging (NCT05045872) | The First Affiliated Hospital with Nanjing Medical University | 2021-09-17 |
| Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery (NCT03678350) | Roswell Park Cancer Institute | 2021-09-17 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine (NCT06147895) | Aribio Lab Co., Ltd. | 2021-09-17 |
| Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants (NCT05032950) | Pfizer | 2021-09-17 |
| Inqovi Maintenance Therapy in Myeloid Neoplasms (NCT04980404) | Massachusetts General Hospital | 2021-09-17 |
| Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors (NCT05048901) | National Health Research Institutes, Taiwan | 2021-09-17 |
| Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients (NCT04888312) | Alligator Bioscience AB | 2021-09-17 |
| A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers (NCT05077462) | AJU Pharm Co., Ltd. | 2021-09-17 |
| Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers (NCT05148962) | Gritstone bio, Inc. | 2021-09-16 |
| Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19) (NCT05113849) | HK inno.N Corporation | 2021-09-16 |
| Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT (NCT05066958) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-09-16 |
| Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor (NCT05009966) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-09-16 |
| Repeated Neurocognitive Measurements in Depressed Patients (NCT04916548) | Rebecca Price | 2021-09-16 |
| Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma (NCT04967196) | Mayo Clinic | 2021-09-16 |
| A Study of SDI-118 in Participants in Remission From Depression (NCT05212116) | Syndesi Therapeutics | 2021-09-16 |
| A Multiple Dose Study of LY3502970 in Healthy Participants (NCT05051566) | Eli Lilly and Company | 2021-09-16 |
| A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and Abdomen (NCT04893798) | Pfizer | 2021-09-16 |
| A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma (NCT04973605) | BeOne Medicines | 2021-09-16 |
| A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) (NCT04809467) | Incyte Corporation | 2021-09-16 |
| Pharmacokinetic Study to Compare Itepekimab Exposure When Administered With an Autoinjector Versus Prefilled Syringe (NCT06114238) | Sanofi | 2021-09-16 |
| A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer (NCT04982926) | Taiho Oncology, Inc. | 2021-09-16 |
| Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies (NCT05528887) | The Affiliated People's Hospital of Ningbo University | 2021-09-16 |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) (NCT05061147) | Maxinovel Pty., Ltd. | 2021-09-16 |
| Text Messaging to Increase Activity in Midlife (NCT04849052) | Massachusetts General Hospital | 2021-09-16 |
| Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection (NCT04765449) | Thomas Jefferson University | 2021-09-15 |
| Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer (NCT05092750) | M.D. Anderson Cancer Center | 2021-09-15 |
| Pemvidutide (ALT-801) DDI Study in Healthy Volunteers (NCT04972396) | Altimmune, Inc. | 2021-09-15 |
| Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19) (NCT04988217) | Pontificia Universidad Catolica de Chile | 2021-09-15 |
| A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer (NCT05027139) | Jazz Pharmaceuticals | 2021-09-15 |
| Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma (NCT05042934) | M.D. Anderson Cancer Center | 2021-09-15 |
| Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes (NCT04831684) | Medical University of South Carolina | 2021-09-15 |
| Plasmapheresis Versus Plasma Infusion from Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression (NCT03887741) | Mayo Clinic | 2021-09-15 |
| Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma (NCT04884035) | Celgene | 2021-09-15 |
| A Study of KL590586 in Patients With Advanced Solid Tumors (NCT05265091) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2021-09-15 |
| Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19 (NCT04684446) | R-Pharm | 2021-09-15 |
| Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (NCT04845217) | University of Louisville | 2021-09-15 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies (NCT05006794) | Gilead Sciences | 2021-09-15 |
| A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors (NCT05039931) | Sichuan Baili Pharmaceutical Co., Ltd. | 2021-09-15 |
| Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation. (NCT04623216) | Novartis Pharmaceuticals | 2021-09-14 |
| A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors (NCT04774718) | Hoffmann-La Roche | 2021-09-14 |
| A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer (NCT05054374) | Memorial Sloan Kettering Cancer Center | 2021-09-14 |
| A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC (NCT04995523) | AstraZeneca | 2021-09-14 |
| Study of ESG401 in Adults With Solid Tumors (NCT04892342) | Shanghai Escugen Biotechnology Co., Ltd | 2021-09-14 |
| A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer (NCT04467515) | Precirix | 2021-09-14 |
| Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane (NCT03930680) | University of Arkansas | 2021-09-14 |
| Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma (NCT04840875) | Beijing Boren Hospital | 2021-09-14 |
| A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes (NCT04747431) | Passage Bio, Inc. | 2021-09-14 |
| Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma (NCT04836195) | Pacylex Pharmaceuticals | 2021-09-14 |
| Donor-Derived CD5 CAR T Cells in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia (NCT05032599) | Beijing Boren Hospital | 2021-09-14 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TB-840 in Healthy Subjects (NCT05045534) | Therasid Bioscience | 2021-09-14 |
| Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers (NCT04596267) | Boston Medical Center | 2021-09-13 |
| A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies (NCT05006716) | BeOne Medicines | 2021-09-13 |
| Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors (NCT04896697) | Xilio Development, Inc. | 2021-09-13 |
| Trial to Evaluate L9LS in Healthy Adults (NCT05019729) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-09-13 |
| A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function (NCT04942964) | Astellas Pharma Global Development, Inc. | 2021-09-13 |
| A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours (NCT04949425) | AstraZeneca | 2021-09-13 |
| Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei (NCT04982146) | Maimónides Biomedical Research Institute of Córdoba | 2021-09-13 |
| A Study of GFH925 in Patients With Advanced Solid Tumors With KRAS G12C Mutations (NCT05005234) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-09-13 |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) (NCT05001282) | Elucida Oncology | 2021-09-13 |
| Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects (NCT04283097) | Kangpu Biopharmaceuticals, Ltd. | 2021-09-13 |
| Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma (NCT04712864) | Legend Biotech USA Inc | 2021-09-13 |
| A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors (NCT04991480) | Artios Pharma Ltd | 2021-09-13 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza (NCT05052697) | Pfizer | 2021-09-13 |
| A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg (NCT04987970) | Chong Kun Dang Pharmaceutical | 2021-09-12 |
| Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT (NCT04764513) | Chinese PLA General Hospital | 2021-09-12 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis (NCT05147779) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-09-12 |
| A Study to Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19 (NCT04953078) | Baiya Phytopharm Co., Ltd. | 2021-09-11 |
| A Bioavailability Study of FL-101 in Healthy Male and Female Subjects (NCT04983732) | Flame Biosciences | 2021-09-11 |
| Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer (NCT04895761) | Providence Health & Services | 2021-09-10 |
| The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer (NCT04991129) | Suzhou Junjing BioSciences Co., Ltd. | 2021-09-10 |
| Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants (NCT05056246) | Amgen | 2021-09-10 |
| Intra-discal Injection of Platelet-rich Plasma (PRP) Enriched With Exosomes in Chronic Low Back Pain (NCT04849429) | Dr. Himanshu Bansal Foundation | 2021-09-10 |
| Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma (NCT04911621) | University Hospital, Antwerp | 2021-09-10 |
| A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults (NCT05040295) | Pfizer | 2021-09-10 |
| Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine (NCT04960397) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-09-10 |
| CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia (NCT04704323) | Catapult Therapeutics | 2021-09-10 |
| HAT for the Treatment of Sepsis Associated With NASTI (NCT05157360) | Ascension Health | 2021-09-10 |
| A Pharmacokinetic Study of Sugammadex in Dialysis Patients (NCT04556721) | Tetsuro Sakai | 2021-09-10 |
| A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets (NCT04817644) | Novo Nordisk A/S | 2021-09-10 |
| Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia (NCT04972227) | Tisento Therapeutics | 2021-09-10 |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors (NCT05415475) | Chongqing Precision Biotech Co., Ltd | 2021-09-10 |
| Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects (NCT05068947) | Graviton Bioscience Corporation | 2021-09-10 |
| Relative Bioavailability Study of HRG2010 in Healthy Subjects (NCT06976346) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-10 |
| Dupilumab_Metastatic NSCLC (NCT05013450) | Thomas Marron | 2021-09-10 |
| Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. (NCT04925674) | Sunshine Lake Pharma Co., Ltd. | 2021-09-10 |
| A Single and Repeat Dose Trial in Participants With Hepatic Impairment (NCT05009680) | Galecto Biotech AB | 2021-09-09 |
| Taste Assessment of Ozanimod (NCT05001152) | Bristol-Myers Squibb | 2021-09-09 |
| A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer (NCT05156424) | Kira Murphy | 2021-09-09 |
| A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers (NCT04879849) | Takeda | 2021-09-09 |
| A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents (NCT05094804) | OncoResponse, Inc. | 2021-09-09 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors (NCT04972981) | ADC Therapeutics S.A. | 2021-09-09 |
| 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability (NCT05029518) | Chengdu SciMount Pharmatech Co., Ltd. | 2021-09-09 |
| A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer (NCT04872608) | Memorial Sloan Kettering Cancer Center | 2021-09-09 |